| 000 | 01894 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513044223.0 | ||
| 264 | 0 | _c19950202 | |
| 008 | 199502s 0 0 eng d | ||
| 022 | _a0027-8424 | ||
| 024 | 7 |
_a10.1073/pnas.91.26.12932 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWang, Z E | |
| 245 | 0 | 0 |
_aInterferon gamma-independent effects of interleukin 12 administered during acute or established infection due to Leishmania major. _h[electronic resource] |
| 260 |
_bProceedings of the National Academy of Sciences of the United States of America _cDec 1994 |
||
| 300 |
_a12932-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Anti-Idiotypic _xadministration & dosage |
| 650 | 0 | 4 |
_aCD4-Positive T-Lymphocytes _ximmunology |
| 650 | 0 | 4 |
_aCytokines _xgenetics |
| 650 | 0 | 4 | _aGene Expression |
| 650 | 0 | 4 |
_aImmunoglobulin D _ximmunology |
| 650 | 0 | 4 |
_aInterferon-gamma _xphysiology |
| 650 | 0 | 4 |
_aInterleukin-10 _xphysiology |
| 650 | 0 | 4 |
_aInterleukin-12 _xadministration & dosage |
| 650 | 0 | 4 |
_aInterleukin-4 _xgenetics |
| 650 | 0 | 4 |
_aInterleukin-5 _xphysiology |
| 650 | 0 | 4 |
_aLeishmania major _ximmunology |
| 650 | 0 | 4 |
_aLeishmaniasis, Cutaneous _ximmunology |
| 650 | 0 | 4 |
_aLymph Nodes _ximmunology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Knockout |
| 650 | 0 | 4 |
_aRNA, Messenger _xgenetics |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aZheng, S | |
| 700 | 1 | _aCorry, D B | |
| 700 | 1 | _aDalton, D K | |
| 700 | 1 | _aSeder, R A | |
| 700 | 1 | _aReiner, S L | |
| 700 | 1 | _aLocksley, R M | |
| 773 | 0 |
_tProceedings of the National Academy of Sciences of the United States of America _gvol. 91 _gno. 26 _gp. 12932-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1073/pnas.91.26.12932 _zAvailable from publisher's website |
| 999 |
_c7808506 _d7808506 |
||